Galapagos NV (GLPG): Price and Financial Metrics

Galapagos NV (GLPG): $25.75

0.12 (+0.47%)

POWR Rating

Component Grades








Add GLPG to Watchlist
Sign Up

Industry: Biotech




#42 of 347

in industry

GLPG Price/Volume Stats

Current price $25.75 52-week high $44.25
Prev. close $25.63 52-week low $25.32
Day low $25.53 Volume 95,600
Day high $25.85 Avg. volume 122,401
50-day MA $28.13 Dividend yield N/A
200-day MA $34.45 Market Cap 1.70B

GLPG Stock Price Chart Interactive Chart >

Galapagos NV (GLPG) Company Bio

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines in areas such as cystic fibrosis, inflammation, and other indications. The company was founded in 1999 and is Mechelen, Belgium.

GLPG Latest News Stream

Event/Time News Detail
Loading, please wait...

GLPG Latest Social Stream

Loading social stream, please wait...

View Full GLPG Social Stream

Latest GLPG News From Around the Web

Below are the latest news stories about GALAPAGOS NV that investors may wish to consider to help them evaluate GLPG as an investment opportunity.

Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

Mechelen, Belgium; 19 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the first patient has been dosed in PAPILIO-1, the Phase 1/2 study to evaluate the safety, efficacy, and feasibility of our seven-day vein-to-vein, point-of-care manufactured BCMA CAR-T candidate, GLPG5301, in adult patients with relapsed/refractory multiple myeloma (rrMM). This is Galapagos’ third oncology CAR-T program in clinical development. GLPG5301 is an autologous, second-generation

Yahoo | December 19, 2023

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023

GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.

InvestorPlace Earnings on InvestorPlace | December 13, 2023

Best Momentum Stocks to Buy for December 13th

GLPG, BBVA and TW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 13, 2023.

Yahoo | December 13, 2023

Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101

Additional safety and efficacy data further support potential of innovative, decentralized approach to CAR-T manufacturing and transformational impact on patients with severe hematologic cancersTwo poster presentations include recent data updates and additional data not included in the ASH abstracts Galapagos to host a Key Opinion Leader (KOL) event with live webcast on Sunday, 10 December 2023 at 11:00 am PT/20:00 CET Mechelen, Belgium; 9 December 2023, 18:00 CET; Galapagos NV (Euronext & NASDA

Yahoo | December 9, 2023

Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023

Mechelen, Belgium; 6 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will host a Key Opinion Leader (KOL) event during the 65th ASH Annual Meeting & Exposition in San Diego, CA, on Sunday, December 10, 2023, from 11:00 am PST to 12:30 pm PST. The in-person event will be held at the San Diego Marriott Gaslamp Quarter in the Presidio Ballroom B/C. To register as an in-person attendee, please click here. To register as a virtual attendee, please click here.

Yahoo | December 7, 2023

Read More 'GLPG' Stories Here

GLPG Price Returns

1-mo -5.57%
3-mo -21.28%
6-mo -36.59%
1-year -37.20%
3-year -64.26%
5-year -79.53%
YTD -36.65%
2023 -8.40%
2022 -19.50%
2021 -44.30%
2020 -52.14%
2019 125.45%

Continue Researching GLPG

Want to see what other sources are saying about Galapagos Nv's financials and stock price? Try the links below:

Galapagos Nv (GLPG) Stock Price | Nasdaq
Galapagos Nv (GLPG) Stock Quote, History and News - Yahoo Finance
Galapagos Nv (GLPG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!